ABSTRACT Recent studies using microarray technologies for the chicken have reported information regarding the effects of specific experimental treatments on gene expression levels often resulting in large gene lists and limitations on the statistical significance levels detected. In most cases, with these limitations, along with thresholds of ±2-fold differences in expression levels, that are used to create these gene lists, much of the biological information may have been overlooked. In this study, a focused 70-mer oligonucleotide microarray was developed to address the apparent limits of detection and issues with multiple testing resulting from the use of microarrays that include only a single spot (probe) for each gene. Gene expression was assayed across the development of the chicken embryonic heart from d 7 to 20 of incubation. When using a mixed-model approach and ANOVA with Bonferroni correction for multiple testing, including replicates within the focused array significantly increased the sensitivity with which differences could be detected across sample groups, as compared with single-spot data. By incorporating replication into the focused array, 50 genes were detected as being differentially expressed in the embryonic heart across the time points sampled. This compares with only 7 genes detected as being differentially expressed when a more typical, less statistically stringent single-spot analysis is conducted. Based on our observations, the use of focused microarrays allows for the thorough investigation of gene expression patterns, with detection of significant changes in gene expression of ±7%. This limit of detection is far superior to that of real-time PCR, which is able to detect significant changes in expression from ±33 to 55%, depending on the specific application. The ability to detect small differences in expression will allow investigators to identify subtle effects that have perhaps been overlooked in many prior assays, including single-spot arrays. Subtle shifts in gene expression are exactly those that occur during embryonic development, nutritional manipulation, and the initial stages of disease before clinical signs appear.
INTRODUCTION
The draft chicken genome was completed and published in 2004, granting the chicken the honor of being the first farm animal to have its genome sequenced (Lamont, 2006; Siegel et al., 2006) . The available genome sequence provides the opportunity to fully implement modern genomic technologies, with great precision, and to accumulate data on the expression patterns of all genes (Siegel et al., 2006) .
Among the latest tools being developed for chicken are microarrays. Oligonucleotides or cDNA are spotted (probes) onto nylon filters or glass slides and hybridized with a target made from an RNA population of interest. Microarray technology provides several advantages for analyzing large populations of genes (Schena et al., 1995) . The greatest advantage is that a large number of genes can be measured in a single assay (Spielbauer and Stahl, 2005) .
Several groups have assembled microarrays containing subsets of chicken cDNA sequences. Affymetrix (Santa Clara, CA) has constructed a GeneChip Chicken Genome array covering nearly 33,000 transcripts, corresponding to more than 28,000 chicken genes (Antin and Konieczka, 2005) . The GeneChip also contains probe sets for detecting 684 viral transcripts. A 13,000-feature cDNA chip has been generated at the Fred Hutchinson Cancer Research Center (Seattle, WA) through the combined efforts of researchers at the Fred Hutchinson Cancer Research Center, the University of Delaware (Newark, DE) , and the Roslin Institute (Roslin, Midlothian, UK; Burnside et al., 2005) . A 1,152 chick embryo cDNA array (Jaszczak et al., 2006 ) and a 5,000 cDNA chicken immune DNA array (Smith et al., 2006) are also available from ARK-Genomics (Roslin, Midlothian, UK). An 8,000-feature metabolic-somatic system chip, a 7,000-feature neuroendocrine-reproductive system chip, and the 14K Del-Mar Chicken Integrated Systems chip are also available (Cogburn et al., 2004) . One limitation of all of these array formats is in their sensitivity for detecting differences in gene expression. Many of these arrays contain only a single spot or replicate for each gene in the array and require significant numbers of technical or biological replicates to detect statistically significant differences.
We have designed a focused array that contains 320 specifically chosen long oligonucleotides, enabling the accurate measurement of key genes and pathways of interest to several research groups at North Carolina State University. The array was customized for a large replication number and provides a valuable, cost effective resource for the investigation of expression patterns in selected genes. Gene ontology data and tentative consensus sequence information are provided for each 70-bp oligonucleotide at the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) archive, accession number GLP6043.
The objective of the present study was to develop a proper analytical method to find differentially expressed genes by using our focused array with its large number of replications per gene. We have selected a representative data set to show the investigation of changes in the expression patterns of genes in the developing chick heart from the stage at which it is readily discernible and removed [embryonic day (E)7] through pipping (E20) as an example of the application of this array method. The expression patterns in the heart through this period of development reflect the patterns of genes involved in cardiac growth, cardiac capacity, and the preparation for hatching. These patterns are not expected to be large in magnitude, as are most microarray experiments, because there has been no experimental manipulation, hormone or drug treatment, or disease challenge, as in the majority of prior works.
MATERIALS AND METHODS

Tissue Sampling
Chicken embryos were obtained from broiler line eggs. Four times during incubation [E7, E15, E19 (internal pipping), and E20 (external pipping)], 8 embryos were killed and the heart was immediately removed, immersed in RNA-Later (Applied Biosystems-Ambion, Foster City, CA) according to the manufacturer's protocol, and stored at −80°C.
RNA Isolation
Total RNA was isolated from each tissue sample (8 from every time point) by using a single-step, modified acid guanidinium thiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) . Briefly, 100 mg of heart tissue was homogenized in RLT buffer (Qiagen, Valencia, CA). The homogenate was then extracted with acidic (pH 4.2) phenol-chloroformisoamyl alcohol (125:24:1). The resulting mixture was separated by centrifugation, yielding an upper aqueous phase, which was then decanted and extracted with chloroform-isoamyl alcohol (49:1), yielding an upper phase containing total RNA. The RNA was precipitated by addition of an equal volume of 100% isopropanol for 2 h and subsequent centrifugation. The RNA pellet was washed with 75% ethanol and then resuspended in diethylpyrocarbonate-treated water. Concentration and quality of the RNA were determined by measuring the absorbance at 260 nm (Nanodrop, NanoDrop Technologies, Wilmington, DE), and RNA were monitored for integrity by agarose gel electrophoresis. Only RNA of sufficient purity, having an absorbance ratio of A260:280 >1.85, was considered for use.
Array Procedure and Processing
Microarrays were manufactured at North Carolina State University by using 70-bp oligonucleotides manufactured by Operon Biotechnologies Inc. (Germantown, MD) and obtained in a 384-well plate format. The sequence of each oligo was based on the 70-mer database generated by TIGR (The Institute for Genomic Research) and currently maintained by the Gene Index Project (http://compbio.dfci.harvard.edu/ tgi/tgipage.html) for the chicken. Oligos were resuspended in array spotting solution and printed (spotted) on UltraGAPS Amino-Silane Coated Slides (Corning Inc., Acton, MA) to produce all the slides used in this study. The slides were printed by using a VersArray Chipwriter Compact Arrayer (Bio-Rad Inc., Waterloo, Ontario, Canada), using 4 slotted pins. Each gene was spotted 3 times (side-by-side) in the same grid, and grids were replicated 4 times on each slide so that each gene was spotted a total of 12 times per array (technical replicates). After printing, the slides were left to dry for 24 h in the printer, and the oligos were then attached to the slide surface on a CL-1000 UV crosslinker (UVP Inc., Upland, CA) set to 6,000 × 100 µJ/cm 2 .
Sample Labeling
The array experimental design was a complete interwoven loop design (Garosi et al., 2005) . From each time point, 4 individual samples were each labeled with Cy3, and 4 individual samples were each labeled with Cy5. Tissue RNA samples were used to produce Cy-dye labeled cDNA by using the indirect labeling technique. We used the ChipShot Indirect Labeling and Clean-up System kit (Promega, Madison, WI) to produce aminoallyl-cDNA, which was labeled either with Cy3 or Cy5 fluorescent dye (Amersham Biosciences Corp., Piscataway, NJ).
Hybridization and Image Acquisition
After the complete interwoven loop design, for every time point there were 8 individually labeled cDNA, and each one was hybridized to a different array. The labeling and hybridization scheme is shown in Figure 1 . Thus, the array loop design included a total of 16 arrays. Each array hybridization included cDNA from 2 distinct time points, with one being labeled with Cy3 and the other being labeled with Cy5. For the prehybridization and hybridization of the microarrays slides, the Pronto Plus! Microarray Hybridization Kit (Corning Inc.) was used. The Cy3-and Cy5-labeled cDNA probes were applied to a prehybridized slide covered with a precleaned glass coverslip (Lifterslip, Portsmouth, NH), and hybridized for 16 h. Microarray slides were scanned on a ScanArray G X PLUS Microarray Scanner (PerkinElmer Life and Analytical Sciences, Shelton, CT) set to 65% laser power.
Quantitative Real-Time PCR
Total RNA from individual hearts (6 from each time point) was reverse-transcribed to produce cDNA in a 20-µL volume containing 1 µg of extracted RNA, using an iScript kit (Bio-Rad, Hercules, CA) according to the manufacturer's protocol. The reaction was incubated at 25°C for 5 min, followed by 30 min at 42°C and 5 min at 85°C. Individual cDNA were diluted 1:20 before amplification. The mRNA expression levels of selected probes were analyzed by quantitative real-time PCR (qPCR) with a Bio-Rad iQ instrument and with iQ-SYBR Green Supermix kits according to the manufacturer's protocols. Gene-specific primers were designed by using Beacon Designer software (Premier Biosoft International, Palo Alto, CA) for SYBR Green detection according to the published cDNA sequences for each of the selected genes (Table 1) .
Thermocycling parameters were as follows: 94°C for 5 min; 50 cycles of 94°C for 30 s, appropriate annealing temperature in degrees Celsius (Table 1) for 30 s, 72°C for 30 s; 72°C for 8 min. Fluorescence measurements were collected at every cycle during the extension step (72°C). Each gene was amplified independently in triplicate within a single instrument run. Standard curves were also generated to determine the efficiency of amplification by pooling undiluted cDNA from the heart samples across all ages and diluting the pooled cDNA to dilutions of 1:5, 1:25, 1:125, and 1:625. Cycle threshold (C t ) values were calculated for each sample, corresponding to the cycle at which the amplification rate was maximal. Gene expression was normalized for RNA loading by using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control. The nfold change was calculated relative to that on E7 by using the DD C t method of Pfaffl (2001), including the efficiencies for both the experimental gene and GAP-DH.
Data Processing and Statistical Analysis
Microarrays. The scanned images were processed by the following procedure. Data files were generated by extracting the intensity raw data for each slide and dye combination by using ScanAlyze Software (Stanford University, Stanford, CA). Intensity data files were then analyzed by using JMP Genomics (SAS Institute Inc., Cary, NC), including an initial log 2 transformation. Data normalization was performed by using locally weighted regression and smoothing, first within array and then across all arrays. Evaluation of the normalization was monitored by distribution analysis of the transformed data. This data set can be found at NCBI GEO and is accessible through GEO Series accession number GPL6043 (Edgar et al., 2002) . The resulting normalized log 2 intensities were analyzed by using a mixed-model ANOVA, as described by Wolfinger et al. (2001) .
The mixed model used to identify significant differentially expressed genes using one gene replicate was
with embryonic age (E) and Cy-dye (Dye) as fixed effects, and slide (S) as a random effect. Mean intensi- Array hybridization scheme for 2-color labeling. Each sampling time point is shown as embryonic day (E)7, E15, E19, and E20. Each array is represented by an individual arrows or bars (16 total). The sample groups located at each end of the respective arrows were hybridized on the same array. Samples at the tail of the arrow were labeled with Cy3 (open) and samples at the arrowhead were labeled with Cy5 (shaded). To complete all comparisons within the design, samples within a time point group were hybridized against a sample from the same time point, which is represented by the bars within each sample group. This results in 8 independent measurements for each time point. Each of these 8 measures corresponded to an individual sample collected and labeled with either Cy3 or Cy5 as shown.
ties were compared by using a threshold of significance based on the false discovery rate (FDR) of P = 0.05 (Benjamini and Hochberg, 1995) . One gene replicate analysis was performed by using only the first spotted replicate for each gene (replicate 1 in the first grid of the array).
The mixed model used to identify significant differentially expressed genes using the high degree of replication was
with embryonic age (E) and Cy-dye (Dye) as fixed effects, and grid × slide (GS) as a random effect. Mean intensities were compared by using a threshold of significance based on a Bonferroni correction of P = 0.05 (Hochberg, 1988) . For the complete array, including all replicates, a mean by grid intensity was calculated for each gene by using the 3 side-by-side probes, resulting in a total of 4 replicated means (1 from each replicated grid) per gene. Real-Time. Data for the C t ratio from 8 random replicates (sample gene C t :sample GAPDH C t ) during embryonic development were subjected to one-way ANO-VA according to the following model:
with embryonic age (E) as the main fixed effect. All statistical analyses were conducted by using JMP software (SAS Institute Inc.).
Pathway and Process Analysis
Biological processes were identified by using the approach of statistical overrepresentation in the Metacore database (GeneGo Inc., St. Joseph, MI), a highly curated Web-based application for identification of gene ontology processes in input gene sets (Nikolsky et al., 2005) . The analysis methodology uses annotation databases and identifies gene ontology biological processes associated with experimentally identified differentially expressed genes, which are then ranked according to their P-value.
Metacore was also used for network analysis as a pathway mapping tool. The list of differentially expressed genes identified experimentally was uploaded to Metacore for analysis and construction of any potential biological network(s). The shortest path algorithm was used to map the shortest path for interaction between the differentially expressed genes.
RESULTS AND DISCUSSION
Focused Arrays
In this study, we used a mixed-model ANOVA to determine the differential gene expression patterns across 4 time points in embryonic development. Our emphasis was on the utility of a focused microarray approach to identify differentially expressed genes when the change in expression levels was moderate to low (±7%). By using a high degree of replication along with the Bonferroni correction, 50 genes were identified as Volcano plots of significance level (P-value) versus expression level difference. Each diamond represents one of 320 genes, with the negative log 10 of the P-value from the gene model plotted against the difference between least squares means for the indicated effect. Plots in column A result from analysis including all of the replicate spots for each gene, whereas those in column B result from the analysis of only a single spot for each gene. The horizontal dashed line represents the testwise threshold of P = 0.05, as determined by the false discovery rate estimation based on the number of tests in each analysis method. A difference of one residual unit represents a 2-fold change, because raw fluorescence intensities are log 2 transformed. being differentially expressed from E7, E15, E19, and E20 in a comparison of each of the individual time periods across development, as is presented in panel A of Figure 1 . The volcano plots provide a visual characterization of the differential expression pattern of genes, with increasing significance level represented on the y-axis and the difference in expression levels as either positive and negative shown on the x-axis. The threshold of significance was determined by Bonferroni correction set at P = 0.05.
When the arrays were analyzed by using only singlespot information for each gene, with FDR set at P = 0.05, as is common in previously reported array studies, only 7 genes were identified as being differentially expressed across the 4 time periods. When the stricter Bonferroni correction was used, no genes were detected as being significantly different. A visual representation of this analysis using FDR is also presented in Figure  2 , panel B. As compared with the analysis including all the replicate spots described above and shown in panel A, there was a noteworthy reduction in genes detected as being significantly differentially expressed. This difference was due to the major contribution of the replicates in eliminating the noise prevalent in microarray experiments.
Our statistical model included multiple tests on individual genes, as do all microarray experiments. Many studies do not adequately deal with multiple testing and rely only on the nominal P-values provided by the statistical model used. Therefore, to protect against false discoveries caused by multiple testing, we used the less restrictive step-up FDR threshold for significant P-values for the single spot and the stricter Bonferroni correction for the high degree of replication. We Table 2 . Genes identified as differentially expressed from embryonic day (E)7 to E20 in the chick embryonic heart, depending on the number of replicates included in the analysis 1
Comparison
Gene name Ascension no. set the FDR at 0.05, meaning that the list of significant genes after applying FDR was expected to contain 5% false positives, which is the primary basis for most of the recently published array studies. The Bonferroniadjusted -log 10 P-value for the complete focused arrays in this experiment was calculated to be 4.6, compared with the Bonferroni-adjusted -log 10 P-value for the single-spot array of 4.7. At this significance limit, no genes were changed significantly in the single-spot analysis. We therefore used the typical FDR detection threshold of 0.05 for analysis of the single-spot array data. We believe that the Bonferroni adjustment with the complete array data set resulted in an elevation of the significance threshold in combination with the increase in tests, thus resulting in the most statistically sound analysis of the array data.
qPCR
Additionally, as a validation of the array results, qPCR was used to determine the apparent changes in gene expression for several genes. First, there must be some recognition of the limitations of qPCR and the sensitivity of the assay to detect differences in starting material levels. In a comprehensive study comparing array data by qPCR with array data by Taqman detection (generally accepted as the most accurate method), Wang et al. (2006) determined that the limits for detecting differences in gene expression varied depending on the relative basal expression level. Differences in gene expression were more easily detected for those that had relatively high levels of expression. This was contrasted with those genes that had moderate to low expression levels. The limit of detection was determined to be ±33% when using a significance threshold of P < 0.05. This limit of detection did not include any correction for multiple testing. When an FDR correction was included, the limit of detection of the change in gene expression by qPCR was determined to be ±55% (Wang et al., 2006) . Acknowledging this limit to the qPCR technique is vital in validation studies, especially for the focused array, which may have detected differences beyond the limits of qPCR detection.
In our study, the following genes were evaluated by real-time PCR when using SYBR Green detection: cardiac troponin T (cTnT), DNA topoisomerase II-β (TOP2B), atrial natriuretic factor (ANF), transcriptional regulator T-box 20 (TBX20), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which served as an internal control for cDNA loading.
During the development of the heart, the chamber myocardium forms locally from the embryonic myocardium of the tubular heart. Atrial natriuretic factor is specifically expressed in this developing chamber myocardium and is one of the first hallmarks of chamber formation (Temsah and Nemer, 2005) . Transcriptional regulator T-box 20 is required for heart tube elongation and progression to chamber formation, as has been shown in knockouts and mice carrying mutations Means of the 4 sampling days normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) within each row (gene) without a common superscript differ significantly (P < 0.05).
x,y
Mean intensities for the 4 sampling days within each row (gene) without a common superscript differ significantly (P < 0.05).
1 cTnT = cardiac troponin T; TOP2B = DNA topoisomerase II-β; TBX20 = transcriptional regulator T-box 20; ANF = atrial natriuretic factor.
2 qPCR = quantitative real-time PCR.
3
The n-fold change was calculated relative to that on E7 comparing the intensity for the arrays or using the DD Cycle threshold (C t ) ratios are shown at the ration of the target gene:normalizer ± SE.
within the gene (Stennard and Harvey, 2005) . Expression of cTnT changes from a high-to low-molecularweight isoform during cardiac muscle development in the chicken and is the cardiac form of troponin, which regulates striated muscle contraction (Yonemura et al., 2002) . Deoxyribonucleic acid topoisomerase II-β has not been characterized as being involved in cardiac development as yet, but has been recognized as being involved in drug-mediated cardiotoxicity (Lyu et al., 2007) . Its role and apparent down-regulation during development of the heart will be the focus of future studies.
The differential expression pattern detected by the microarray, as well as validation by qPCR for these genes, is shown in Table 3 . The pattern of expression across all 4 of the genes tested was consistent between the focused microarray method and the qPCR method. This validation provides support for the ability of the focused array to assess gene expression levels.
Biological Processes and Gene Networks
Animal development is fashioned by conserved signaling pathways that orchestrate morphogenesis, pattern formation, and cell differentiation, complex processes operating jointly in different parts of an embryo and in stages associated with sequential gene activation. Monitoring local and temporal changes in gene expression can provide insight into how genes and regulatory signals work together to guide development.
MetaCore pathway analysis of the significant genes identified many known processes involved in heart development. A comparison between the developmental time points showed that in each pairwise comparison, biological processes were identified that involved the actual embryonic heart development. A comparison of E7 to E20 produced many more significant differences, but ones that were not relevant in the developmental time course. In the comparison between E7 and E15, biological processes that are involved with muscle cell development and differentiation, which is consistent with the development of the heart, appeared as relevant (Table 4) . Between E15 and E17, the significant genes were found to be involved in biological processes that are linked to gas transport, blood circulation, and heart contraction ( Table 5) . Between E19 and E20, biological processes identified by the MetaCore database were primarily linked protein metabolic processes (Table 6 ). The cardiovascular system is the first system that is developed in the embryo and is easily discernible early in the developing chick. Early cardiovascular development is a complex process involving the coordination, differentiation, and interaction of distinct cell lineages to form the heart and the diverse array of arteries, veins, and capillaries required to supply oxygen and nutrients to all tissues. By E7, the chicken heart is fully formed and is easily dissectible and removed. From E7 through the remainder of incubation, the chicken heart continues to grow and provide the driving force behind adequate nutrient flow and gas exchange for the embryo. All the biological processes described in Tables 4, 5 , and 6 are relevant to the functional and developmental courses at work in the developing heart. At several periods during the remainder of development, transition points occur that may put additional stress on the heart to provide adequate circulation. The development of the avian embryo is supported by 3 gas-exchange organ systems: the yolk sac, the chorioallantoic membrane, and the lungs. The vascular portion of the yolk sac is the principal gas exchange organ during early development (Baumann and Meuer, 1992) . At approximately E8, the allantoic sac develops and fuses with the chorion to create the chorioallantoic membrane (Wangensteen and Rahn, 1970-1971) , which fully supports gas exchange until approximately E19. At E20 before hatching, there is a decline in the allantoic gas exchange and regression of the chorioallantoic membrane (Visschedijk, 1968a,b,c) , and any metabolic requirements by the embryo shift to dependence on what oxygen the lungs can provide (Menna and Mortola, 2002) . These transition periods may be responsible for changes in gene expression in the embryonic heart, including stress response, growth, and metabolic demands at hatch.
An alternative approach is to develop a de novo network based on biological interactions connecting the genes identified as being differentially expressed in our study (Figure 3) . A biological network analysis was conducted by using the Metacore pathway mapping tool (http://www.genego.com) and provided information that can be used to supplement our initial list of genes included in the array. The shortest path network analysis further strengthened our list of genes by identifying other genes that were likely involved in the chicken embryo developmental process. It is also clear that even though the number of differentially expressed genes identified by this array reduced with age (Table  2) , the number of interactions of significant genes with other genes annotated in Metacore increased with age ( Figure 3 ). This may be related to the developmental timing of the shift between the greater expression of genes involved in heart physical growth and genes involved in metabolic functions at hatch.
By using the resulting networks (Figure 3 ), we can select influential genes that can be potentially added to the array. As an example, we can point out the SP1 gene, a transcription factor involved in, among other things, collagen formation by activating genes involved in extracellular matrix accumulation (Verrecchia et al., 2001) . Disruption of this target gene causes retarded embryonic development in mice (Marin et al., 1997) . In our network construction analysis, SP1 is downstream from several other genes significantly affected by the chick embryonic ages studied herein. One can see it in all 3 comparisons, between E7 and E15 ( Figure 3A) , between E15 and E19 ( Figure 3B ), and again between E19 and E20 ( Figure 3C ). Another candidate gene for addition to the array is β-catenin, which appears in the comparison between E7 and E15 ( Figure 3A ). β-Catenin is a binding protein that, according to the GenoGo annotation database, is implicated in processes including the patterning of blood vessels and the morphogenesis of the embryonic epithelium. It has also been pointed out in available network information that β-catenin is the target of a specific inhibition drug called exisulind (sulindac metabolite; Rice et al., 2003) , which opens a range of possibilities for new research opportunities involving the effects of gene inhibition on embryonic Figure 3 . Biological network analysis of differentially expressed genes during embryonic heart development. These 3 networks were produced by using the shortest path algorithms of the Metacore software suite (GeneGo Inc., St. Joseph, MI). Nodes with circles indicate identified genes present in our analysis. The lines indicate interactions of activation, induction, modification, or direct binding. The broad shaded connections indicate consecutive outgoing interactions of genes determined to be significantly different in the particular networks. A complete legend to the symbols representing each gene is provided in an online-only data supplement (http://ps.fass.org/content/vol87/issue11/). heart formation and function. Apart from SP-1, the cMyc gene appears to be downstream from many genes shown in Figure 3C , so it could be an important candidate gene for future study. This gene is a transcription factor that activates genes involved in cell proliferation, but it is also involved in sensitizing cells to death stimuli, including the response to hypoxic conditions (Brunelle et al., 2004) . These are just some examples of how the ability to detect and identify subtle differences in gene expression within an experiment and how performing a network and biological processes analysis can further enhance the meaning and usefulness of data results when using this focused array method approach.
In conclusion, several recent reports looking at the effects on gene expression as a result of challenge by pathogen or comparison across vast phenotypic differences have included at least the FDR in the detection of differentially expressed genes (Bliss et al., 2005; Rubin et al., 2007) . These studies have used duplicate spot arrays. In reviewing the genes that were identified as differentially expressed, those detected with the lowest fold-change in expression showed a 2.07-and 1.4-fold change, respectively. Most early array reports limited the genes they investigated to those that had changes in expression greater that ±2-fold. We believe that extensive amounts of biological information may have been overlooked. In many studies in which the application of some form of multiple-testing correction to the significance levels was absent, extensive lists of genes have been reported, which may only confuse the results and may simply be the result of the noisy nature of array experiments.
The conclusions of this study are that the use of microarray analysis to identify genes that are undergoing subtle changes in expression patterns, as were observed in the chicken embryonic heart, requires a high degree of replication. Analysis with a traditional single-spot array is insufficient to detect the small differences in gene expression that occur in some developmental processes. These small differences are akin to those one would expect to encounter in similar studies involving subtle changes in growth rate, feed efficiency, and nutritional manipulation. These types of experiments are quite different from challenge or disease studies, which significantly perturb the biological system.
With the inclusion of replicates in microarrays, the increased power of sample size has a tremendous impact on the identification of differentially expressed genes, as shown in our comparison of analysis methods. With detection limits as low as ±7% using our focused microarray approach, extremely small differences in gene expression can be detected and measured. The construction of a focused array is limited in its scope by the number of genes that can be printed on the substrate. Based on our current format of triplicate adjacent spots replicated 4 times on the array slide, as many as 768 genes can be assayed simultaneously. The degree of accuracy with which the measurements can be made for this number of genes is far superior to any current technology for the cost involved (Wang et al., 2006) . We anticipate expanding the foundation of our focused microarray to include supplementary pathways and processes for the evaluation of additional tissues and stages in the growth and development of poultry in future studies.
